Thereisincreasing evidence forarelationship between bacterial infections and several cardiovasculardisorders.Althoughthe precisem echanism(s) underlying this associationi su nknown, the direct activation of platelets by bacteria is one possibility. Individual strains of S. sanguis activateplatelets in anon-uniform, donor-dependent manner. In the current study,plateleta ggregation profilesw ereobtained forf ourteen donors in response to four strains of S. sanguis (2017-78, 133-79,SK112, SK108a) and one of S. gordonii (SK8) . Thep latelets from all donors respondedtostrains 2017-78and 133-79,whereasstrains SK112, SK8 and SK108acausedaggregation in one,fiveand twelve donors, respectively. Immunoglobulin G( IgG)b inding to strains Keywords Platelet,Fc γ RIIA, polymorphisms, IgG, Streptococcus sanguis 2017-78, 133-79and SK108a were significantlygreaterthan to strains SK112 and SK8. Absorption of IgG by strain2 017-78 caused significant decreasesi nI gG binding, and plateleta ggregation in response,toa ll strains.Single-strandc onformational polymorphisms were observed in the Fcγ RIIA gene from four donors. Sequencing revealedt wo knowna nd twon ovel point mutations, none of which correlated with the aggregation profile.Thus,plateletactivation to the various strains dependsona common IgG and, whileinmost casesthe levelofIgG bindingto S. sanguis determinesplateletresponsiveness, neither the levels of IgG nor Fcγ RIIA polymorphisms can fullyaccount fordonor variability. 
Introduction
There is someevidencefor arelationship between bacterial infectionsa nd the pathogenesis of several cardiovascular or cerebovasculard isorders (1) . Epidemiological and aetiological studiessupportalink between infection with Chlamydiapneumoniae and the incidenceo fc oronary heart disease, including atherosclerosis and myocardialinfarction (2, 3) . Forexample, C. pneumoniae has beenidentified in atherosclerotic plaques (4, 5) , and ah igh proportion of patients with coronaryh eartd isease have circulating C. pneumoniae -specific immune complexes (5, 6) . However, these observations,a nd their implications,a re somewhat contentious (7, 8) .
Similarly an association between Helicobacter pylori infections and cardiovasculard isorders has been proposed (9, 10) , though againthis has beenwidely challenged (11) . Finallyrelationships,a lthough not necessarilyc ausal,h avea lso been proposedbetween bronchial (12) and,particularly, oral (13, 14) infections with the development of cardiovasculardisease.
Themechanisms underlying the relationship between bacteriali nfections and cardiovasculard isorders are unknown, although avarietyofpossibilities have beenpostulated. Infectious organisms, such as C. pneumoniae,are potentialinitiatorsofthe earlyendothelial dysfunction whichservesasthe initial focus for atherosclerotic lesions (15) .Similarlyinfecting organismsmay induce cytokine-mediated inflammatoryr esponses recognized to playar ole in both the development and progression of cardiovasculard isorders such as atherosclerosisa nd angina (15, 16) . Finallythe direct activation of platelets by bacteria provides aplausible link between infection and cardiovasculardisorders, includingthrombosis, angina and atherosclerosis (6) .
Arangeofbacterial species,including C. (17) (18) (19) (20) . However, the mechanisms of plateleta ctivation appear diverse. For example, C. pneumoniae-induced platelet activation involves a rolef or LPS (17) ,w hereasgram positive organisms, whichd o not contain LPS,can induce platelet activation. Va riousgroups have proposedthat individual species of bacteria induce platelet activation by collagen-,A DP-, PA F-or immunoglobulin G-(IgG) likemechanisms (21) (22) (23) (24) . Furthermore, S. pyogenes and S. aureus activate platelets by ad ual mechanism involving the bacterial adhesion to platelets and an independent activation step involving common, specificI gG (24) .I tw as subsequently hypothesised that antibody titre influenced the variability of individual donor'splateletactivation in response to S. pyogenes and S. aureus (24) .
The mechanismof S. sanguis-inducedaggregation remains unclear.The expression of the platelet α IIb β 3 integrin, in an "open conformation" with subsequent fibrinogen binding (25) ,i s required. Thus this is atrueactivation process, ratherthan apassivecross-linkingaction. Indeed roles for the assembly of complement proteins on the bacterial surface (26) , av arietyofplateletreceptors(e.g. α 2 β 1 and the GPIb/V/IXcomplex) (27) ,IgG (25, 28) , plateletcyclo-oxygenase activity and ADP production (21, 29) have allbeen suggested.
The role of IgG and itsl ow affinity plateletr eceptor, Fcγ RIIA, in plateletactivation by S. sanguis is of particular interest. Theremoval of IgGfrom plasmaorblockade of IgG binding to Fcγ RIIA, prevents plateletaggregation in response to some S. sanguis strains (25) ,consistent with arequirement forFc γ RIIA in the activation process. Polymorphic variation in IgG receptors, includingF c γ RIIA, have beens hown to criticallya ffect their ability to interact with IgG, leading to ap ossible role for IgG receptor allotypes in variousa utoimmune and infectious diseases (30) .Interestingly, polymorphic variation of platelet receptors,s uch as α 2 β 1 ,g lycoprotein Ib and the α IIb β 3 integrin, have beenshown to impact upon an individual'splateletresponsiveness and susceptibilitytothrombosis (31, 32) .
The objective of the current study wastodetermine the potentialroles playedbyIgG titre,IgG binding and Fcγ RIIA allotype in the inter-strain and inter-donor variation observedin S. sanguis-inducedplateletaggregation. 
Materials andmethods

Materials
Bloodcollection
The study wasa pprovedb yt he ResearchE thicsB oardo ft he University of Manitobaand informed consent wasobtained from all volunteers.B lood wasc ollectedb yv enipunctureo fh uman volunteers and platelet rich plasma prepared as previously reported (28) .Analiquotwas centrifuged at 8500 gfor 30 stoyield platelet-poorplasma (PPP) whichwas storedat-20°C until use.
Bacteriaand cultureconditions
Bacterial cells were prepared as previouslyr eported (28) .The absorbanceat660 nm wasrecorded and the number of bacteriain the suspension wascalculated according to astandard curve of absorbancev ersus bacteria/ml, the lattero btained using aP etroff-Hausser counting chamber (28) .
Platelet aggregation
Aggregation of platelets in plasma wasm easured in aP ayton dualc hannela ggregometer as previouslyd escribed (28) .P latelets were challengedf or 20 mins.w ith each strain at ap latelet:bacteriaratio of 1:2. If there wasnochange in light transmission by 20 mins., the donor/strain combination wasdefined as non-responding. All aggregations were carried outi nd uplicate on twoseparateoccasions.
Anti-S. sanguis IgGtitre
The levels of IgG in plasma binding to the bacteriaw ere measured by enzyme-linked immunosorbent assay( ELISA). ELISA plates were coated with bacteria(100µ g/ml dryweight) overnightat4°C. Theplatesw ere blocked (0.1% BSAinPBSTween; 1hr.;room temperature),washed with PBS-Tween, then incubatedwith the PPP samples, seriallydiluted(1:50 -1:1600) in PBS-Tween containing 0.1%g lobulin-free albumin (3hr.; roomt emperature). After washing, the plates were incubated witha nti-human IgG HRP (1:1000 in PBS-Tween with 0.1% globulin-free albumin; 1hr.; room temperature) and washedi n PBS-Tween. O-phenylenediamine substrate(0.4mg in 10ml citrate-phosphate buffer,pH5.0 and 40µ Lhydrogen peroxide)was added and subsequent colourd evelopment read at 450nmi na BioRADMicroplate Reader Model550. IgG binding to individual strains of S. sanguis wasquantified on threeseparateoccasions. Data presented from1:400 dilution.
Depletionof S. sanguis 2017-78-specific antibody An aliquoto fP PP (3.0ml) wasi ncubated with S. sanguis 2017-78 (300µ L) during gentles tirring at 4°Cf or 2hr.I gGbound bacteria were removedbycentrifugation at (three x1min at 8500 xg ). Thea bove procedurew as repeated with af resh 300 µ Lof S. sanguis 2017-78 to maximize depletion. The level of IgG binding following absorption with 2017-78 was measured by ELISA, as described above.
IgGisolation by QAE-sephadexchromatography QAE-sephadexwas swollen and packedinbuffer(ethylene diamine/acetic acid; pH 7.0).F ollowing column equilibration with the same buffer,P PP (1.0ml) wasa pplied to the column and allowedtopassthrough. Double diffusion of the eluate wasperformedonagarosegel using anti-humanIgG to determine which fractionsc ontained IgG.T hose fractions containing IgG were combined and stored at -20°Cuntil use.
Single-strand conformational polymorphism analysis Exons 1-7 of Fcγ RIIA were amplifiedbypolymerase chain reaction (PCR) using intronic primers flanking each exon (Table 1) and genomic DNAastemplate. Subsequent to amplification, all samples were treated as previously described (33) .
DNAsequence analysis
DNAwas amplifiedbyPCR using primers for exons 3, 4, 5and 7( Table1 )a nd amplified products isolatedu sing aQ IAquick Gel Extraction Kit according to manufacturer'si nstructions. DNAs equencing using forward and reverse primers (Table 1) wasconductedatthe Centre for Applied Genomics, Toronto, Canada.The differencesr eported were observedi nb oth the forward and reverse sequences.
Results
Platelet aggregation in responseto S. sanguis
The platelets of all donors (n=14) aggregatedw hen challenged with S. sanguis strains 2017-78 or 133-79 (Fig. 1) . As previouslyreported,incontrast to soluble agonists such as collagen, ADP or thromboxane A 2 ,the onset of aggregation wasmarkedly delayedi nr esponset ot he bacteria (28) .S trainS K112,p reviouslyreported as anon-aggregating strain, caused the aggregation of platelets from onedonor (Fig.1) . Strains SK108a and SK8 caused the aggregation of platelets from 12 and 5donors, respectively (Fig.1) .
IgGbinding to S. sanguis
The levels of each donors'IgG binding to the respective strains were determinedbyELISA (Fig. 2) mean±SEM; n=14; p<0.05) were significantly lowert han the IgG binding to strains 2017-78 and SK108a (Fig. 2) . The meanlevel of IgGbindingtoall strains in donorswhere aggregation wasi nducedw as 19.78±0.79 µg IgG/mg bacteria (mean±SEM; n=46) whichw as significantlyh ighert han that bound in donors where aggregation did not occur (14.52±1.02µg IgG/mg bacteria; mean±SEM;n =24; p<0.001). Al ogistic regression wasusedtoquantify the relationshipbetween IgGbinding and the likelihoodo fa ggregation ( χ 2 =1 3.88, with 1d f, p=0.000195). This confirmed the existenceofahighlysignificant,c oncentration-dependent, relationshipb etween IgGb inding and the induction of aggregation. Of the 70 donor/straincombinations, 54 were consistent with an IgGb indingl evel of 13.63µ gI gG/mg bacteria approximating at hreshold level required to produce aggregation. Thep latelets from oned onor aggregatedinresponseto2017-78, twoinresponsetoSK8 and one in response to 133-79 withI gG binding to the respective strain of less than1 3.63 µg IgG/mg. In contrast, the platelets from four donors failedtoaggregate in response to SK112, seven in response to SK8 and oneinresponsetoSK108a, although in eachIgG binding to the strain wasabove the threshold level.
DepletionofIgG binding to S. sanguis strain 2017-78
Absorptionofplasma by strain 2017-78 caused significant decreases in IgG binding to 2017-78( 53.3±5.4%; n=3), SK112 (55.0±5.6%; n=3), SK8 (27.3±7.9%; n=3), SK108a (34.3±4.9%; n=3) and 133-79 (32.3±11.0%; n=3). Interestingly, the depletion of plasma IgG by binding to strain 2017-78 inhibited plateletaggregation in response to allfivestrains of bacteriatested (Fig. 3) , although aggregation in response to collagenr emained intact (datanot shown).
Supplementation of plasma of SK8 non-responders by IgG
IgG wasisolated from the donor (donor 7) whose platelets aggregatedinresponsetoall five strains. This isolatedIgG wasadded to the plasma of the four donors whose platelets had failedtorespond to strain SK8. The subsequent addition of SK8 failedto induce platelet aggregation in this IgG-supplementedp lasma (Fig. 4) .
Single-strand conformational polymorphism and DNA sequence analyses
Single-strand conformationalp olymorphism (SSCP)a nalysis wasconductedoneach exon of the Fcγ RIIA gene. SSCPs were observedinexons 3, 4, 5and 7inthe amplified DNAproducts from donors 5, 7, 13 and 14.DNA sequencing revealed twopoint mutations in exon 3, resulting in aGLN63TRPsubstitution and as ingle pointm utation in exon 4, resulting in aH IS167ARG substitution in allfour donors. Each of these polymorphismshas been previously reported (34) .T wo novelp olymorphisms, in exon 5and exon 7, were identifiedinall fourdonors, butthese did not alter the amino acid sequence (PRO215PROa nd PRO293PRO) of Fcγ RIIA. Thepresence of none of these polymorphisms correlated with the plateleta ggregation profile (Fig. 1 ).
Discussion
The relationship betweenbacterial infection and cardiovascular disordershas been the subject of some controversy. In particular, the potentialrole playedbyoral pathogensinatherosclerosisand thrombosis is unclear.S everal extensive prospective cohort studieshavedemonstrated thatperiodontaldiseaseisarisk factor for cardiovascular disease, independent of otheraccepted risk factors(35-38), although the significance of the correlation has beenq uestioned (39) .M ost studies have focused on the consequences of bacteraemiasw hich occur several timesd aily. 
Figure4:Effects of IgG supplementationonnon-responsive platelets. Theaggregationofplatelets from donors 7(D-7)or13
(D-13) in response to S. sanguis strain2017-78 or to S. gordonii strain SK8 (added at arrow) was determinedbyincreasinglight transmission. IgGfromdonor 7(arespondertoSK8) was addedtothe plasma of donor13(anon-respondertoSK8); howevernosubsequent aggregationofplatelets from donor13was observed (D-13 +D-7 IgG).
These low-levelbacteraemiasmay initiate hostresponses altering coagulability,e ndothelial and vesselw alli ntegrity,a ccentuating inflammatoryr esponses and stimulating plateletf unction, therebyresulting in atherosclerotic and thrombotic events (40) .
S. sanguis is frequently isolatedf rom dentalp laque and, while not consideredaperiodontalpathogen,ithas been linked to the progression of variouscardiovasculardiseases (20) .Several groups have reported the activation of platelets by S. sanguis in as train-and donor-dependent manner ( 20, 28, 41, 42) . The mechanism of S. sanguis-inducedplateletactivation is unclear although arole for IgG binding to Fcγ RIIA, the lowaffinity IgG receptor on platelets,has been suggested (25, 28, 43) .
In the present study four strains of S. sanguis and oneof S. gordonii were used to examine both strainand donor dependency withrespect to IgG binding. Plateletaggregation wasobserved in alldonors in response to both strains 2017-78, widelystudied as an "aggregating strain" of S. sanguis,and 133-79. In contrast, the platelets from onlyone donor responded to SK112, astrain previouslyreported as a"non-aggregating strain". Intermediate donor responses were observedw ith strains SK108a and SK8. These data confirmthe strain and donor variability of the platelet response to S. sanguis and showthat S. gordonii cancauseplateleta ggregation in ad onor-dependent manner. Depletiono f IgG, by binding to 2017-78, abolished both IgG binding, and aggregation in response, to not only2017-78 butalso to the other strains. Thus, plateletactivation to the variousstrains would appeartobedependentupon the presenceofacommon IgG,and thus it is unlikelythat the strain dependencyofaggregation occursasaresult of sub-typevariation in IgG. Sjöbringetal. similarlyconcludedthat specific IgG wasrequired forplateletactivation by S. pyogenes and S. aureus (24) .However,itisunclear whether ac ommon epitope on all threeb acterial species is responsiblefor IgG-mediated plateletactivation.
Therelationship between plasma IgG and donorvariation in plateleta ggregation wasa ssessedb yd etermining the levels of IgG binding to individual strains and correlating these levels with aggregation. In general, platelet aggregation occurred when levels of IgG binding above athreshold levelof13.63 µg IgG/mg bacteria were observed. This levela ccounted for5 4o ft he 70 donor/strain combinations and suggests that the levelo fI gG binding determinesplateletresponsivenesstoindividual strains in approximately 70% of the situations. Such arelationship was suggested,but not demonstrated,for S. pyogenes and S. aureus (24) .
The platelets from five donors aggregatedatIgG binding levels belowthe threshold,whereasthe platelets from twelvedonors failedt or espond at levels of IgG binding above the predicted threshold. Consequently, in these cases the donor variation cannot be explained by levels of IgG binding alone. The addition of IgG isolated from the plasmao fa" responder" failedt os upporta ggregation in a" non-responder", confirming thatthe (sub)-type of IgG does not confer variability. Overall,these data suggest that, while in most cases the levelof IgG binding to S. sanguis determinesplateletresponsiveness, in some cases an inherent property of platelets confers donorplasma specificity.
S. sanguis-induced, IgG-mediated platelet activation is an illdefined process. Although the initial plateletr eceptor fora dhesion to bacteria is unknown, rolesfor both α 2 β 1 and the GPIb/ V/IXc omplexd uring both the adhesive and activation phases have beens uggested. Subsequently S. sanguis-associated IgG binds to its high affinity receptor on platelets, Fcγ RIIA, leading to ac ascade of signaling eventsa nd ultimatelyp lateleta ggregation (28) . It is plausible thatpolymorphic variation in anyof the plateletreceptors(eitheradhesive or activation) for bacterial components mayaccount fordonor variability.
Polymorphisms in plateletr eceptorsh aveb een widelyr eported and,insome cases, implicated in avarietyofthrombotic situations. Forexample several polymorphisms in the GPIbgene have beenr eported (44, 45) i ncluding at least one whichi nfluencesthe pathogenesis of ischemic stroke, even after adjusting for conventional cardiovascularrisk factors (46) . Similarly a polymorphism in the α 2 gene has beencorrelated with earlyage stoke (47) .
Of significance forthe current work, the HIS131ARG polymorphismi nF c γ RIIA has been reported nott oa ffect platelet function (48) . Similarlyinthe present study this polymorphism did not impact on the plateletresponses to the bacterial species examined. Thus, in the currentstudy,polymorphic variation of Fcγ RIIA could not account forthe variability of plateletaggregation observedamongst the donors.
Takentogether,the data indicatesthat IgG levels partially, excluding Fcγ RIIA polymorphisms, can account fordonor variability in plateletresponsivenessto S. sanguis.Otherfactorsinvolved mayinclude polymorphism variation in otherreceptors, or avariation in complement assembly on the plateletsurface.
